Compare Costco Wholesale Corporation (COST) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Costco Wholesale Corporation vs Medpace Holdings Inc — how do they compare? Costco Wholesale Corporation trades at $948.99 (market cap $418.79B), while Medpace Holdings Inc trades at $597.39 (market cap $16.90B). The key difference: Costco Wholesale Corporation is far larger — about 24.8× Medpace Holdings Inc's market cap, and Costco Wholesale Corporation pays a 0.62% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| COST | MEDP | |
|---|---|---|
Market Cap | $418.79B | $16.90B |
Sector | Consumer Staples | Technology |
52-Week High | $1.09K | $620.59 |
52-Week Low | $849.63 | $393.42 |
Enterprise Value | $406.93B | $16.52B |
Dividend Yield | 0.62% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Costco Wholesale Corporation (COST) trades at $948.43, down 0.45% on the day, with technical indicators signaling a bearish trend amid neutral oscillators. The stock shows strong fundamentals with revenue growth to $275.24 billion in 2025 and consistent earnings beats, though it missed Q1 2026 estimates. Recent news highlights membership fee hikes and robust March sales, while analyst consensus remains bullish with a $1,120 price target.
The outlook for COST is positive due to steady revenue growth and high analyst confidence, but risks include elevated valuation multiples and competitive pressures. Investment opportunity lies in its scalable business model and membership-driven profits, though investors should monitor earnings consistency and macroeconomic impacts on consumer spending.
MEDP trades at $600.00, down 0.4% on the day, with a bullish technical signal driven by moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $4.25, and raised full-year guidance. Revenue growth is robust, with 2026 projected at $2.8 billion, though valuation multiples like a P/E of 35.58 and P/B of 38.95 are elevated. Net cash flow is expected to turn positive in 2026, and institutional activity is mixed, with some funds increasing stakes while others trim positions.
Outlook is positive due to earnings momentum and record bookings, but risks include high valuation sensitivity and a shareholder lawsuit investigation. Analyst consensus is a $599.57 price target with a 'Hold' bias, suggesting limited near-term upside from current levels amid growth-priced expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Costco Wholesale Corporation
The leading warehouse club, Costco has 815 stores worldwide (at the end of fiscal 2021), with most sales derived in the United States (72%) and Canada (14%). It sells memberships that allow customers to shop in its warehouses, which feature low prices on a limited product assortment. Costco mainly caters to individual shoppers, but roughly 20% of paid members carry business memberships. Food and sundries accounted for 40% of fiscal 2021 sales, with non-food merchandise 29%, warehouse ancillary and other businesses (such as fuel and pharmacy) nearly 17%, and fresh food 14%. Costco's warehouses average around 146,000 square feet
Read more on COST →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
